Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01708499 · ClinicalTrials.gov registry record · NA
Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal Tissue
A NA study, sponsored by Ulthera.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
NCT01708499 is a NA study that has completed, run by Ulthera. The registered enrollment target is 24 participants.
The verdict
NCT01708499, a NA study, has completed, sponsored by Ulthera.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
Study Summary
Enrolled subjects will receive one UltherapyTM treatment on the abdomen. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
Interventions
- DEVICE Ulthera System Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-03 |
| Est. Completion | 2013-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01708499
The ClinicalTrials.gov registry entry for NCT01708499 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ulthera System Treatment is the first listed.
NCT01708499 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01708499 about?
NCT01708499 is a clinical study titled "Feasibility Study: Evaluation of the Ulthera® System for Treatment of Abdominal Tissue". Enrolled subjects will receive one UltherapyTM treatment on the abdomen. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.
What is the current status of trial NCT01708499?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2012-03. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01708499?
The interventions under investigation include: Ulthera System Treatment (DEVICE).
Who is sponsoring clinical trial NCT01708499?
This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.